Transgenic Plant Produces Omega-3s

Scientists identify a set of genes that direct the synthesis of omega-3 fatty acids in the seed oil of Camelina sativa.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Camelina sativaWIKIMEDIA, JOHANN GEORG STURM/JACOB STURMResearchers at UK biotech Rothamsted Research have generated a transgenic plant that produces omega-3 long-chain polyunsaturated fatty acids, which are vital for normal metabolism. In a paper published in The Plant Journal last month (December 6), the researchers described a set of genes that regulate the synthesis of omega-3 fatty acids in the seed oil of the crop Camelina sativa. With directed expression of these genes, the transgenic C. sativa produces omega-3s at levels “equivalent to those in fish oils, and represent a sustainable, terrestrial source of these fatty acids,” the authors wrote in their paper.

“[W]e had to understand really well the fundamental processes that underpin oil synthesis in seeds of plants in order to be able to reconstitute the synthesis of EPA and DHA in the seeds of Camelina,” study coauthor Olga Sayanova said in a statement.

Study coauthor Johnathan Napier told New Scientist that while transgenic C. sativa cannot alone meet global demand for omega-3 fatty acid production, the plants could help “significantly take the pressure off fish stocks.” While fish oils are the primary source of natural omega-3s, some plant oils also contain these fatty acids. Aside from the transgenic C. sativa, omega-3 fatty acids are found flaxseed oil and hemp oil, among other plant sources.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies